Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases

Detlef Zillikens*, Kurt Derfler, Rüdiger Eming, Gerhard Fierlbeck, Matthias Goebeler, Michael Hertl, Silke C. Hofmann, Franz Karlhofer, Ocko Kautz, Martin Nitschke, Andreas Opitz, Sven Quist, Christian Rose, Stefan Schanz, Enno Schmidt, Iakov Shimanovich, Michael Michael, Fabian Ziller

*Corresponding author for this work
53 Citations (Scopus)

Abstract

Despite the use of high-dose systemic corticosteroids in combination with other immunosuppressants, in some patients with autoimmune bullous diseases only insufficient improvement is achieved. In these cases and in acute severe disease, adjuvant immunoapheresis has been increasingly used. A consensus meeting was held in mid-2005 in Hamburg, aiming at developing guidelines for the use of immunoapheresis in the treatment of autoimmune bullous diseases.This paper summarizes the experts' recommendations.

Translated title of the contributionEmpfehlungen für die anwendung der immunapherese bei der therapie bullöser autoimmundermatosen
Original languageEnglish
JournalJDDG - Journal of the German Society of Dermatology
Volume5
Issue number10
Pages (from-to)881-887
Number of pages7
ISSN1610-0379
DOIs
Publication statusPublished - 10.2007

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases'. Together they form a unique fingerprint.

Cite this